Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
3.460
-0.230 (-6.23%)
At close: Nov 20, 2024, 4:00 PM
3.490
+0.030 (0.87%)
After-hours: Nov 20, 2024, 5:43 PM EST
Personalis Market Cap
Personalis has a market cap or net worth of $196.17 million as of November 21, 2024. Its market cap has increased by 281.43% in one year.
Market Cap
196.17M
Enterprise Value
97.68M
1-Year Change
281.43%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $196.17M, a decrease of -76.86%. That is a compound annual growth rate of -23.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 209.21M | 103.18% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | 340.45M | -59.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 206.92M |
| Sera Prognostics | 205.34M |
| Corbus Pharmaceuticals Holdings | 204.13M |
| XBiotech | 203.32M |
| Enanta Pharmaceuticals | 202.77M |
| Jin Medical International | 201.95M |
| Solid Biosciences | 199.77M |
| Lexeo Therapeutics | 198.40M |